The PennZone

CHADDS FORD, Pa., Aug. 28, 2024 ~ ClariMed, Inc., a renowned company known for its human-centered approach to medical device development and regulatory services, has recently announced the opening of its new office in Leeds, UK. This move is part of the company's global expansion strategy and aims to strengthen its presence in Europe while taking advantage of the region's thriving healthcare innovation ecosystem.

The new Leeds office will serve as a hub for ClariMed's expanding medical device user research capabilities. With access to a diverse pool of study participants, the company will be able to enhance its human factors engineering insights. Additionally, being in close proximity to world-class healthcare institutions and professionals will provide valuable opportunities for collaboration and innovation in user-centered design.

Kelley Kendle, CEO of ClariMed, expressed her excitement about this milestone in the company's growth. "This expansion not only broadens our geographical reach but also allows us to tap into the region's rich talent pool and innovative spirit," she said. Kendle believes that Leeds' strategic location and thriving healthcare sector align perfectly with ClariMed's mission to drive human-centered innovation in medical device development.

More on The PennZone

• Dividend Stock Guru Unveils High Yield Dividend Stock Research Reports
• New Bethany Hosted "Food is Medicine" Roundtable with Community Leaders on April 1
• Charging Into the $30 Billion Heart Failure Market with Late-Stage Momentum, Breakthrough Data, & Strong Financial Backing: Cardiol Therapeutics $CRDL
• Eastern Adjustment Group, LLP Provides Property Loss Advocacy and Claim Support
• All American Home Renovators: Transforming Bathrooms into Masterpieces, One Home at a Time

Julian Dixon, Associate Director of Human Factors and Site Lead of the Cambridge, UK office, highlighted how this expansion showcases ClariMed's commitment to excellence and unique company culture. "The Leeds office will enable us to further diversify our participant base and recruit top talent from across Northern England," Dixon stated. He believes that this enhanced capability will result in more comprehensive insights for clients, ultimately leading to safer and more effective medical devices.

Jessica Köhne, Site Lead for the new Leeds office, emphasized the strategic importance of this location. "Leeds is at the heart of the UK's health innovation," she said. "Our new office is strategically positioned to leverage the city's world-class universities, research institutions, and the Leeds Innovation District." Köhne believes that this location will allow them to form stronger partnerships with local healthcare providers and tech innovators, bringing fresh perspectives to their human factors research and further enhancing their ability to deliver impactful human-centered insights. She also expressed excitement about contributing to the region's growing reputation as a hub for medical device innovation while expanding ClariMed's capabilities to serve their global client base.

More on The PennZone

• Bold Beauty Project Celebrates Anniversary with Collaborative Exhibition at FIU's Miami Beach Urban Studios
• Pacific Emblem Company Launches "Happy 250th Birthday America" Collection and Proud Supporter of the Gary Sinise Foundation
• Black Lion Indie Film Festival Returns May 1–3, 2026 with Film, Art, Networking, and Opportunities for Emerging Creatives
• Bold Beauty Project Announces Exhibition at Palazzo Mora Venice, Italy
• Porter's Day Care Empowers Philadelphia's Future Through 45+ Years of Excellence

This strategic expansion aligns with ClariMed's vision to become the worldwide leader in human-centered regulatory and development services for medical products. By establishing a presence in Leeds, the company reinforces its commitment to driving meaningful advancements in healthcare and shaping a future where innovative, user-friendly medical devices are accessible to all. With this new office, ClariMed is well-positioned to continue its mission of putting people at the center of medical device development and regulation.

---

Show All News | Disclaimer | Report Violation